8h30 : Welcome coffee
SESSION 1
9h : Role of glucose sensors and hepatokine signaling in liver physiopathology Catherine Postic
9h30 : Role of the de novo ceramide synthesis pathway in hepatocytes: effects on carbohydrate homeostasis Céline Cruciani
10h : Insulin signaling and fatty acid metabolism in liver pathophysiology Marion Regnier
10h30 : Role of the hepatic endothelium in the development of MASH Pierre-Emmanuel Rautou
11h : Coffee break
KEYNOTE
11h30 : The liver in metabolic complications Stephan Herzig
12h30 : Lunch Break
SESSION 2
13h30 : Lipid metabolism and the control of the senescence program Mario Pende
14h : Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes Jean-Francois Gautier
14h30 : Deciphering the role of macrophages in MASH onset Camille Bleriot
15h : Coffee break
SESSION 3
15h30 : Multi-Omics analysis of an animal model of MASH: Insights from metabolomics, transcriptomics, lipidomics, and immunological profiling Amine Toubal
16h : Impact of diet on microbiota and cardiometabolic diseases Soraya Taleb
